The 5th U.S. Circuit Court of Appeals has ruled that mifepristone must be obtained in person. This decision affects the distribution and accessibility of this medication used in medication abortion.
6.5
30d signal volume
By Threat Layer
Top Signals
View all signals →Details →
A federal appeals court (5th Circuit) blocked an FDA rule from 2023 that had allowed wider access to mifepristone, a medication used for abortion. This decision restricts one of the primary methods for obtaining abortion medication in states with abortion bans.
6.5